跳至主要内容
临床试验/NCT07180238
NCT07180238已完成不适用

Concept Elicitation and Patient Experience Mapping in Sepsis-associated Acute Kidney Injury

Novartis Pharmaceuticals1 个研究点 分布在 1 个国家目标入组 28 人开始时间: 2025年5月1日最近更新:

试验速览

阶段
不适用
状态
已完成
入组人数
28
试验地点
1
主要终点
Patient perspective on sign, symptoms and impacts of SA-AKI

研究概览

简要总结

This is a concept elicitation study on patient's experiences of Sepsis-associated Acute Kidney Injury (SA-AKI)

详细描述

The purpose of this study is to elicit concepts of interests in patients who experienced SA-AKI. The study also aims to map experiences from patient and caregiver perspectives, including treatment pathways and barriers to SA-AKI treatment, the burden of SA-AKI and unmet needs, and the disease's humanistic, societal, and economic impacts. This study is a cross-sectional, non-interventional qualitative interview study of up to 30 people who have experienced SA-AKI from the US and Germany. Participants will be screened for eligibility, provide consent, and complete a virtual, hybrid 60-minute semi-structured concept elicitation (CE) and patient experience interview. Transcripts will be reviewed by analysts and analysed according to a qualitative analysis plan including a thematic analysis of the coded transcripts. This is a minimal risk study. All information will be kept confidential, and information will be stored on a secure network which is only accessible to the study team.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Cross Sectional

入排标准

年龄范围
18 Years 至 85 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Potential participants who were diagnosed with SA-AKI (KDIGO stage I, II or III) must meet the following eligibility criteria:
  • ≥18 to ≤ 85 years of age
  • First diagnosis of SA-AKI at least 6 months prior to screening date, but no more than 10 years
  • Admitted due to sepsis and/or AKI to intensive care unit (ICU), intermediate care unit (IMCU), or high-dependency care unit, or developed sepsis and/or AKI during their inpatient hospital stay.
  • Resident of country of study (US or Germany)
  • Access to computer, tablet, or smartphone with internet connection
  • Willing to participate in an audio recorded interview
  • Participants will be required to present confirmation of diagnosis (COD) rather than relying on a self-reported diagnosis. Sepsis and AKI diagnoses will be confirmed through one of the following:
  • Copy of medical records (e.g., portable document format [PDF] file of electronic health record)
  • Physician confirmation of diagnosis of sepsis and AKI (post-sepsis)
  • Potential caregiver participants must meet the following criteria:
  • ≥18 to ≤ 85 years of age
  • Primary caregiver/care-partner for eligible participant who experienced SA-AKI
  • Resident of country of study (US or Germany)
  • Access to computer, tablet, or smartphone with internet connection
  • Willing to participate in an audio recorded interview

排除标准

  • Potential participants are not eligible if they meet any of the following criteria:
  • Less than age of majority in locality (Participant is not considered an adult in their country or region)
  • Not willing to participate in an audio recorded interview
  • Not able to participate in the interview or complete required study surveys, based on the discretion of the study team

结局指标

主要结局

Patient perspective on sign, symptoms and impacts of SA-AKI

时间窗: Up to 3 months

A 60-min qualitative interview will be conducted and transcripts will be coded to assess which signs, symptoms and impacts of SA-AKI have been experienced by the participant

次要结局

  • Patient experiences on treatment pathways and barriers to SA-AKI treatment, the burden of SA-AKI and unmet needs, and the humanistic, societal, and economic impacts(Up to 3 months)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验